Divalproex Sodium

Divalproex Sodium is a stable coordination compound of valproic acid and sodium valproate in a 1:1 molar ratio, providing the same anticonvulsant and mood-stabilising effects as valproate while reducing GI side effects through slower dissolution. Simson Pharma's Divalproex Sodium reference standard and impurities support compendial testing for this widely prescribed antiepileptic and mood stabiliser.

Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Divalproex Sodium Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.

Pharmaceutical Reference Standards / Impurity Standards

Divalproex Sodium
Butyl 2-propylpentanoate
Propyl 2-propylhexanoate
2,2-Dipropylhexanoic acid
(E)-2,2-Dipropylhex-3-enoic acid
2-Butyl-2-propylmalonamide
2-propoxycarbonyl-2-propylpentanoic acid
propyl 2-propylpentanoate